StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.36−0.05 (-3.87%)

Close on Nov 17, 2026Market cap $34.67MP/E –Yield –

Serina Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Serina Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $130.00K. For fiscal 2025 it was $130.00K, up 132.1% from the year before. The highest annual figure on record is $3.15M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$130.00K+132.1%
FY2024Dec 31, 2024$56.00K-98.2%
FY2023Dec 31, 2023$3.15M+9173.5%
FY2022Dec 31, 2022$34.00K-76.4%
FY2021Dec 31, 2021$144.00K-60.1%
FY2020Dec 31, 2020$361.00K-79.1%
FY2019Dec 31, 2019$1.73M+23.8%
FY2018Dec 31, 2018$1.40M-0.6%
FY2017Dec 31, 2017$1.40M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$130.00K+2500.0%
Q1 FY2025Mar 31, 2025$0-100.0%
Q3 FY2024Sep 30, 2024$14.00K-51.7%
Q2 FY2024Jun 30, 2024$51.00K+628.6%
Q1 FY2024Mar 31, 2024$5.00K-83.3%
Q4 FY2023Dec 31, 2023$3.09M+38487.5%
Q3 FY2023Sep 30, 2023$29.00K+222.2%
Q2 FY2023Jun 30, 2023$7.00K-41.7%
Q1 FY2023Mar 31, 2023$30.00K+500.0%
Q4 FY2022Dec 31, 2022$8.00K-70.4%
Q3 FY2022Sep 30, 2022$9.00K-62.5%
Q2 FY2022Jun 30, 2022$12.00K-67.6%
Q1 FY2022Mar 31, 2022$5.00K-91.1%
Q4 FY2021Dec 31, 2021$27.00K-82.9%
Q3 FY2021Sep 30, 2021$24.00K-65.2%
Q2 FY2021Jun 30, 2021$37.00K-17.8%
Q1 FY2021Mar 31, 2021$56.00K-37.1%
Q4 FY2020Dec 31, 2020$158.00K-71.2%
Q3 FY2020Sep 30, 2020$69.00K-83.2%
Q2 FY2020Jun 30, 2020$45.00K-88.2%
Q1 FY2020Mar 31, 2020$89.00K-77.1%
Q4 FY2019Dec 31, 2019$549.00K+75.4%
Q3 FY2019Sep 30, 2019$411.00K+8.2%
Q2 FY2019Jun 30, 2019$380.00K-18.1%
Q1 FY2019Mar 31, 2019$388.00K+62.3%
Q4 FY2018Dec 31, 2018$313.00K–
Q3 FY2018Sep 30, 2018$380.00K–
Q2 FY2018Jun 30, 2018$464.00K–
Q1 FY2018Mar 31, 2018$239.00K–

More Serina Therapeutics figures

See a number that looks wrong?